Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-023385

Options or other derivatives

  • Chief Executive Officer acquired 7,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Collard Craig A Chief Executive Officer 2023-04-03 Grant or award · Employee Stock Option (Right to Buy) +3,000,000 3,000,000 D
Collard Craig A Chief Executive Officer 2023-04-03 Grant or award · Restricted Stock Units +250,000 250,000 D
Collard Craig A Chief Executive Officer 2023-04-03 Grant or award · Employee Performance Stock Option (Right to Buy) +4,250,000 4,250,000 D
Loading xslF345X04/doc4.xml…